Search

Your search keyword '"Geloven, Nan van"' showing total 5 results
Start Over Author "Geloven, Nan van" Publisher figshare
5 results on '"Geloven, Nan van"'

1. Additional file 2: of Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice â the ECSTATIC study: a cluster randomised non-inferiority trial

Author

Luymes, Clare, Poortvliet, Rosalinde, Geloven, Nan Van, Waal, Margot De, Drewes, Yvonne, Blom, Jeanet, Smidt, Nynke, Assendelft, Willem, Hout, Wilbert Van Den, Ruijter, Wouter De, and Mattijs Numans

Subjects
3. Good health
Abstract

Deprescribing guideline. Table S1. Examples of dose-lowering schemes. (DOCX 18 kb)

2. Additional file 2: of Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice â the ECSTATIC study: a cluster randomised non-inferiority trial

Author

Luymes, Clare, Poortvliet, Rosalinde, Geloven, Nan Van, Waal, Margot De, Drewes, Yvonne, Blom, Jeanet, Smidt, Nynke, Assendelft, Willem, Hout, Wilbert Van Den, Ruijter, Wouter De, and Mattijs Numans

Subjects
3. Good health
Abstract

Deprescribing guideline. Table S1. Examples of dose-lowering schemes. (DOCX 18 kb)

3. Additional file 1: of Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice â the ECSTATIC study: a cluster randomised non-inferiority trial

Author

Luymes, Clare, Poortvliet, Rosalinde, Geloven, Nan Van, Waal, Margot De, Drewes, Yvonne, Blom, Jeanet, Smidt, Nynke, Assendelft, Willem, Hout, Wilbert Van Den, Ruijter, Wouter De, and Mattijs Numans

Subjects
education, cardiovascular diseases, 3. Good health
Abstract

Inclusion and exclusion criteria of the Evaluating Cessation of Statins and Antihypertensive Treatment in Primary Care Trial, as approved by the Medical Ethics Committee of Leiden University Medical Centre. (DOCX 22 kb)

4. Additional file 3: of Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice – the ECSTATIC study: a cluster randomised non-inferiority trial

Author

Luymes, Clare, Poortvliet, Rosalinde, Geloven, Nan Van, Waal, Margot De, Drewes, Yvonne, Blom, Jeanet, Smidt, Nynke, Assendelft, Willem, Hout, Wilbert Van Den, Ruijter, Wouter De, and Mattijs Numans

Subjects
health care economics and organizations, 3. Good health
Abstract

Cost-effectiveness analysis. Table S2. Costs (in £) for the preparation of the intervention, per selected patient. Table S3. Costs (in £) and QALYs per patient in usual care group and intervention group. Figure S1. EuroQol Utility at t = 0, t = 3, t = 6, t = 12 and t = 24 in the usual care group and the intention. Figure S2. Cost-effectiveness acceptability curve showing the probability that an attempt to deprescribe preventive cardiovascular medication is cost-effective compared to usual care. (DOCX 66 kb)

5. Additional file 1: of Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice â the ECSTATIC study: a cluster randomised non-inferiority trial

Author

Luymes, Clare, Poortvliet, Rosalinde, Geloven, Nan Van, Waal, Margot De, Drewes, Yvonne, Blom, Jeanet, Smidt, Nynke, Assendelft, Willem, Hout, Wilbert Van Den, Ruijter, Wouter De, and Mattijs Numans

Subjects
education, cardiovascular diseases, 3. Good health
Abstract

Inclusion and exclusion criteria of the Evaluating Cessation of Statins and Antihypertensive Treatment in Primary Care Trial, as approved by the Medical Ethics Committee of Leiden University Medical Centre. (DOCX 22 kb)

Catalog

Books, media, physical & digital resources
See catalog results